Form 3/A - Initial statement of beneficial ownership of securities: [Amend]
SEC Accession No. 0001104659-22-050538
Filing Date
2022-04-26
Accepted
2022-04-26 20:56:00
Documents
3
Period of Report
2021-10-21

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tm2213646-1_3aseq1.html 3/A  
1 OWNERSHIP DOCUMENT tm2213646-1_3aseq1.xml 3/A 5050
2 EXHIBIT 24.1 tm2213646d1_ex24-1.htm EX-24.1 8060
3 EXHIBIT 24.2 tm2213646d1_ex24-2.htm EX-24.2 7990
  Complete submission text file 0001104659-22-050538.txt   23082
Mailing Address 125 SOUTH CLARK STREET, SUITE 750 CHICAGO IL 60603
Business Address 125 SOUTH CLARK STREET, SUITE 750 CHICAGO IL 60603 (312) 253-9800
Enfusion, Inc. (Issuer) CIK: 0001868912 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 7372 Services-Prepackaged Software

Mailing Address C/O ENFUSION INC. 125 SOUTH CLARK ST. STE. 750 CHICAGO IL 60603
Business Address
Hammoud Tarek (Reporting) CIK: 0001880790 (see all company filings)

Type: 3/A | Act: 34 | File No.: 001-40949 | Film No.: 22855987

Mailing Address C/O ENFUSION, INC. 125 SOUTH CLARK STREET, SUITE 750 CHICAGO IL 60603
Business Address C/O ENFUSION, INC. 125 SOUTH CLARK STREET, SUITE 750 CHICAGO IL 60603 312-253-9800
LRA Ventures, LLC (Reporting) CIK: 0001912134 (see all company filings)

State of Incorp.: FL | Fiscal Year End: 1231
Type: 3/A | Act: 34 | File No.: 001-40949 | Film No.: 22855986